Search research articles
Contact Us
Filters
Showing results (101-110 of 140) with videos related to
Page
of 14
Sort By:
Annals of the Rheumatic Diseases
|
February 14, 2012
Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort
John Bowes, Pauline Ho, Edward Flynn, et al.
The Journal of Rheumatology
|
April 3, 2020
Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases
Matthew L Thomas, Gavin Shaddick, Rachel Charlton, et al.
The New England Journal of Medicine
|
September 21, 2007
A polymorphism in the CTGF promoter region associated with systemic sclerosis
Carmen Fonseca, Gisela E Lindahl, Markella Ponticos, et al.
Annals of the Rheumatic Diseases
|
February 26, 2011
Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris
John Bowes, Steve Eyre, Edward Flynn, et al.
The Journal of Rheumatology
|
December 4, 2009
Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study
Sahena Haque, Caroline Gordon, David Isenberg, et al.
Rheumatology (Oxford, England)
|
October 8, 2013
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)
Maria J Cuadrado, Maria L Bertolaccini, Paul T Seed, et al.
The Journal of Rheumatology
|
December 17, 2018
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
Ana-Maria Orbai, Richard Holland, Ying Ying Leung, et al.
Arthritis and Rheumatism
|
August 29, 2009
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis
Vinod Chandran, Alice Gottlieb, Richard J Cook, et al.
Annals of the Rheumatic Diseases
|
April 30, 2015
PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus
John Bowes, Sabine Loehr, Ashley Budu-Aggrey, et al.
Annals of the Rheumatic Diseases
|
August 20, 2017
Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis
John Bowes, James Ashcroft, Nick Dand, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 140) with videos related to
Sort By:
Page
of 14
Annals of the Rheumatic Diseases
|
February 14, 2012
Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort
John Bowes, Pauline Ho, Edward Flynn, et al.
The Journal of Rheumatology
|
April 3, 2020
Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases
Matthew L Thomas, Gavin Shaddick, Rachel Charlton, et al.
The New England Journal of Medicine
|
September 21, 2007
A polymorphism in the CTGF promoter region associated with systemic sclerosis
Carmen Fonseca, Gisela E Lindahl, Markella Ponticos, et al.
Annals of the Rheumatic Diseases
|
February 26, 2011
Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris
John Bowes, Steve Eyre, Edward Flynn, et al.
The Journal of Rheumatology
|
December 4, 2009
Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study
Sahena Haque, Caroline Gordon, David Isenberg, et al.
Rheumatology (Oxford, England)
|
October 8, 2013
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)
Maria J Cuadrado, Maria L Bertolaccini, Paul T Seed, et al.
The Journal of Rheumatology
|
December 17, 2018
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
Ana-Maria Orbai, Richard Holland, Ying Ying Leung, et al.
Arthritis and Rheumatism
|
August 29, 2009
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis
Vinod Chandran, Alice Gottlieb, Richard J Cook, et al.
Annals of the Rheumatic Diseases
|
April 30, 2015
PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus
John Bowes, Sabine Loehr, Ashley Budu-Aggrey, et al.
Annals of the Rheumatic Diseases
|
August 20, 2017
Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis
John Bowes, James Ashcroft, Nick Dand, et al.
Page
of 14